BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-309@pharmaconomics
DTSTAMP:20260707T034512Z
DTSTART;VALUE=DATE:20251230
DTEND;VALUE=DATE:20251231
SUMMARY:OTLK CRL — ONS-5010/LYTENAVA™ (bevacizumab-vikg)
DESCRIPTION:An FDA complete response letter on ONS-5010/LYTENAVA™ (bevacizumab-vikg) for retinal diseases is in focus around Dec 30\, 2025.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1649989/000110465926065992/tm2615583d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/309
URL:https://www.pharmaconomics.com/e/309
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:OTLK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR